Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories
AffiliationCancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UK.
MetadataShow full item record
AbstractNon-small-cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Although advances are being made towards earlier detection and the development of impactful targeted therapies and immunotherapies, the 5-year survival of patients with advanced disease is still below 20%. Effective cancer research relies on pre-clinical model systems that accurately reflect the evolutionary course of disease progression and mimic patient responses to therapy. Here, we review pre-clinical models, including genetically engineered mouse models and patient-derived materials, such as cell lines, primary cell cultures, explant cultures and xenografts, that are currently being used to interrogate NSCLC evolution from pre-invasive disease through locally invasive cancer to the metastatic colonization of distant organ sites.
CitationHynds RE, Frese KK, Pearce DR, Gronroos E, Dive C, Swanton C. Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories. Open Biol. 2021;11(1):200247.
- Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
- Authors: Medical Advisory Secretariat.
- Issue date: 2010
- Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
- Authors: Shi R, Radulovich N, Ng C, Liu N, Notsuda H, Cabanero M, Martins-Filho SN, Raghavan V, Li Q, Mer AS, Rosen JC, Li M, Wang YH, Tamblyn L, Pham NA, Haibe-Kains B, Liu G, Moghal N, Tsao MS
- Issue date: 2020 Mar 1
- Circulating tumor cells and CDX models as a tool for preclinical drug development.
- Authors: Lallo A, Schenk MW, Frese KK, Blackhall F, Dive C
- Issue date: 2017 Aug
- Transgenic Mouse Models in Cancer Research.
- Authors: Lampreht Tratar U, Horvat S, Cemazar M
- Issue date: 2018
- Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
- Authors: Lee HW, Lee JI, Lee SJ, Cho HJ, Song HJ, Jeong DE, Seo YJ, Shin S, Joung JG, Kwon YJ, Choi YL, Park WY, Lee HM, Seol HJ, Shim YM, Joo KM, Nam DH
- Issue date: 2015 Mar 1